The Costs of Weaponizing the U.S. IP System

Center for Strategic and International Studies  |  Chris Borges

U.S. proposals to condition intellectual property rights on national origin threaten to undermine global IP protections and expose American firms to Chinese retaliation. American companies file approximately 40,000 patent applications annually in China, leaving them vulnerable if Beijing reciprocates with nationalistic legal restrictions. Modifying access to U.S. patents based on geopolitical alignment undermines foundational international principles of non-discrimination and reciprocity established under multilateral frameworks.

These policy shifts risk fragmenting the global legal environment that enables U.S. firms to commercialize, license, and monetize core technologies worldwide. Furthermore, restricting IP protections creates friction for foreign capital, technical expertise, and cross-border commercial partnerships essential for rebuilding domestic industrial capacity across critical sectors such as semiconductor manufacturing, advanced batteries, shipbuilding, and robotics. Sacrificing predictable international legal protections to penalize foreign competitors ultimately degrades the open innovation ecosystem that sustains long-term American technological leadership and economic security.

Comment

Weaponising legal protections directly threatens capital inflows required under initiatives like the CHIPS and Science Act of 2022. Advanced foreign semiconductor foundries reliant on non-discriminatory patent assurances may alter technology transfer protocols or reduce direct fabrication investments within the United States. This structural friction undermines domestic supply chain re-shoring efforts in capital-intensive dual-use sectors. Consequently, narrowing patent accessibility creates a self-inflicted bottleneck for long-term defence industrial base modernisation.

Strategic Question for Discussion

If geopolitical restrictions on patent rights weaken foreign technology transfers, how will the United States balance the protection of critical IP with the domestic execution targets of the CHIPS and Science Act?

Share your assessment in the comments below.

To read in details click here